Guadalquiver, Jezza L.

HRN: 25-25-20  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2024
AMPICILLIN 1GM (VIAL)
06/05/2024
06/07/2024
IV
2grams
Q6hrs
G1P0, Leaking BOW
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: